Euro
USD
British Pound
NULL
![MAP2K7 Antibody (C-Term) [APR08340G]](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/1280x1280/products/869943/1162010/logo__92149.1659788186__50286.1659866042.png?c=2 "MAP2K7 Antibody (C-Term) [APR08340G]"){kind=logo}
![MAP2K7 Antibody (C-Term) [APR08340G]](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/100x100/products/869943/1162010/logo__92149.1659788186__50286.1659866042.png?c=2 "MAP2K7 Antibody (C-Term) [APR08340G]"){kind=logo}
Product Description
MAP2K7 Antibody (C-Term) [APR08340G] | Leading Biology
Product Category: Polyclonal Antibodies
Host: Rabbit
Species Reactivity: Rat
Specificity: This MAP2K7 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 325-360 amino acids of human MAP2K7.
Cellular Localisation: Nucleus. Cytoplasm.
Molecular Weight: 47485
Clone: Polyclonal
Gene Name: MAP2K7
Gene ID: 5609
Function: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074) .
Summary: Tissue Location: Ubiquitous; with highest level of expression in skeletal muscle. Isoform 3 is found at low levels in placenta, fetal liver, and skeletal muscle.
Form: N/A
Storage: Store at +4°C short term. For long-term storage, aliquot and store at -20°C or below. Stable for 12 months at -20°C. Avoid repeated freeze-thaw cycles.
Application: WB
Dilution: WB--1:2000
Synonyms: Dual specificity mitogen-activated protein kinase kinase 7, MAP kinase kinase 7, MAPKK 7, JNK-activating kinase 2, MAPK/ERK kinase 7, MEK 7, Stress-activated protein kinase kinase 4, SAPK kinase 4, SAPKK-4, SAPKK4, c-Jun N-terminal kinase kinase 2, JNK kinase 2, JNKK 2, MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4
![MAP2K7 Antibody (C-Term) [APR08340G]](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/500x659/products/869943/1162010/logo__92149.1659788186__50286.1659866042.png?c=2 "MAP2K7 Antibody (C-Term) [APR08340G]"){kind=logo}
![MAP2K7 Antibody (C-Term) [APR08320G]](https://cdn11.bigcommerce.com/s-452hpg8iuh/images/stencil/500x659/products/869954/1162021/logo__92149.1659788186__87375.1659866051.png?c=2 "MAP2K7 Antibody (C-Term) [APR08320G]"){kind=logo}
